• linkedin
  • Increase Font
  • Sharebar

    Every New FDA Drug Approval in 2017

    The last 12 drugs approved in the year, along with the other 34.

     

    Prevymis logo

    PREVYMIS (letermovir), Merck

    Indications: Prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients [R+] of an allogeneic hematopoietic stem cell transplant (HSCT).

    Dosage: 480 mg administered once daily orally or as an intravenous (IV) infusion over 1 hour through 100 days post-transplant. If PREVYMIS is coadministered with cyclosporine, the dosage of PREVYMIS should be decreased to 240 mg once daily.

    Contraindications: Pimozide, Ergot alkaloids, and pitavastatin and simvastatin when co-administered with cyclosporine.

    Click here to read the full label

    Previous ButtonNext Button

     

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available